Other languages ImpediMed Limited

Equities

Delayed Australian S.E. Other stock markets 05:55:22 30/04/2024 am IST			5-day change	1st Jan Change
0.083 ^AUD	-6.74%		-7.78%	-42.76%

17/04	Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	MT
17/04	Ord Minnett Starts ImpediMed at Speculative Buy, Price Target is AU$0.16	MT

ImpediMed to Present Chronic Breast Cancer-Related Lymphedema Study Results at American Society of Breast Surgeons Annual Meeting	11/04
Impedimed Names Independent Non-Executive Chair	27/02
ImpediMed Narrows Loss in Fiscal H1, Revenue Declines; Shares Fall 7%	27/02
ImpediMed Limited Reports Earnings Results for the Half Year Ended December 31, 2023	27/02
ImpediMed Says New Guidelines for Lymphedema Detection Will Help Company Sales	14/02
ImpediMed CEO, CFO Step Down; Shares Fall 11%	20/11
ImpediMed Limited Announces CEO Changes	20/11
ImpediMed Limited Announces Management Changes	20/11
ImpediMed Secures Payor Clearance for Spectroscopy Device in the US; Shares Rise 4%	03/11
ImpediMed Limited Announces Resignation of Mrs. Janet West AM as Non-Executive Director	03/23/03
Impedimed Limited Announces Board Changes	28/23/28
ImpediMed Appoints Medical Chief; Shares Down 3%	27/23/27
ImpediMed Limited Announce the Appointment of Steven Chen as Chief Medical Officer	27/23/27
Impedimed Widens Fiscal 2023 Loss; Shares Down 3%	31/23/31
ImpediMed Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/23/31
ImpediMed Limited Shareholders Received a Letter from the Board	16/23/16
ImpediMed Limited Receives Notice from Acadia Park Pty Ltd	03/23/03
ImpediMed Limited Receives Notice from Acadia Park Pty Ltd	03/23/03
ImpediMed Limited Receives Notice from Acadia Park Pty Ltd to Remove Directors	31/23/31
ImpediMed Limited Appoints Daniel Sharp as Director	03/23/03

No results for this search